Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Influenza A Hemagglutinin Passage Bias Sites and Host Specificity Mutations.

Lee RTC, Chang HH, Russell CA, Lipsitch M, Maurer-Stroh S.

Cells. 2019 Aug 22;8(9). pii: E958. doi: 10.3390/cells8090958.

2.

The Geographic Variation of Surveillance and Zoonotic Spillover Potential of Influenza Viruses in Domestic Poultry and Swine.

Berger KA, Pigott DM, Tomlinson F, Godding D, Maurer-Stroh S, Taye B, Sirota FL, Han A, Lee RTC, Gunalan V, Eisenhaber F, Hay SI, Russell CA.

Open Forum Infect Dis. 2018 Nov 27;5(12):ofy318. doi: 10.1093/ofid/ofy318. eCollection 2018 Dec.

3.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017.

Lackenby A, Besselaar TG, Daniels RS, Fry A, Gregory V, Gubareva LV, Huang W, Hurt AC, Leang SK, Lee RTC, Lo J, Lollis L, Maurer-Stroh S, Odagiri T, Pereyaslov D, Takashita E, Wang D, Zhang W, Meijer A.

Antiviral Res. 2018 Sep;157:38-46. doi: 10.1016/j.antiviral.2018.07.001. Epub 2018 Jul 3.

4.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.

Hurt AC, Besselaar TG, Daniels RS, Ermetal B, Fry A, Gubareva L, Huang W, Lackenby A, Lee RT, Lo J, Maurer-Stroh S, Nguyen HT, Pereyaslov D, Rebelo-de-Andrade H, Siqueira MM, Takashita E, Tashiro M, Tilmanis D, Wang D, Zhang W, Meijer A.

Antiviral Res. 2016 Aug;132:178-85. doi: 10.1016/j.antiviral.2016.06.001. Epub 2016 Jun 3. Review.

5.

HIV-1 adaptation to low levels of CCR5 results in V3 and V2 loop changes that increase envelope pathogenicity, CCR5 affinity and decrease susceptibility to Maraviroc.

Garg H, Lee RT, Maurer-Stroh S, Joshi A.

Virology. 2016 Jun;493:86-99. doi: 10.1016/j.virol.2016.03.010. Epub 2016 Mar 24.

6.

Influenza A(H5N8) Virus Similar to Strain in Korea Causing Highly Pathogenic Avian Influenza in Germany.

Harder T, Maurer-Stroh S, Pohlmann A, Starick E, Höreth-Böntgen D, Albrecht K, Pannwitz G, Teifke J, Gunalan V, Lee RT, Sauter-Louis C, Homeier T, Staubach C, Wolf C, Strebelow G, Höper D, Grund C, Conraths FJ, Mettenleiter TC, Beer M.

Emerg Infect Dis. 2015 May;21(5):860-3. doi: 10.3201/eid2105.141897.

7.

Influenza viruses with B/Yamagata- and B/Victoria-like neuraminidases are differentially affected by mutations that alter antiviral susceptibility.

Farrukee R, Leang SK, Butler J, Lee RT, Maurer-Stroh S, Tilmanis D, Sullivan S, Mosse J, Barr IG, Hurt AC.

J Antimicrob Chemother. 2015 Jul;70(7):2004-12. doi: 10.1093/jac/dkv065. Epub 2015 Mar 18.

PMID:
25786478
8.

The contrasting phylodynamics of human influenza B viruses.

Vijaykrishna D, Holmes EC, Joseph U, Fourment M, Su YC, Halpin R, Lee RT, Deng YM, Gunalan V, Lin X, Stockwell TB, Fedorova NB, Zhou B, Spirason N, Kühnert D, Bošková V, Stadler T, Costa AM, Dwyer DE, Huang QS, Jennings LC, Rawlinson W, Sullivan SG, Hurt AC, Maurer-Stroh S, Wentworth DE, Smith GJ, Barr IG.

Elife. 2015 Jan 16;4:e05055. doi: 10.7554/eLife.05055.

9.

Genetic signatures of HIV-1 envelope-mediated bystander apoptosis.

Joshi A, Lee RT, Mohl J, Sedano M, Khong WX, Ng OT, Maurer-Stroh S, Garg H.

J Biol Chem. 2014 Jan 31;289(5):2497-514. doi: 10.1074/jbc.M113.514018. Epub 2013 Nov 21.

10.

Identification of conserved motifs in the West Nile virus envelope essential for particle secretion.

Garg H, Lee RT, Tek NO, Maurer-Stroh S, Joshi A.

BMC Microbiol. 2013 Sep 4;13:197. doi: 10.1186/1471-2180-13-197.

11.

Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret model.

Guarnaccia T, Carolan LA, Maurer-Stroh S, Lee RT, Job E, Reading PC, Petrie S, McCaw JM, McVernon J, Hurt AC, Kelso A, Mosse J, Barr IG, Laurie KL.

PLoS Pathog. 2013;9(5):e1003354. doi: 10.1371/journal.ppat.1003354. Epub 2013 May 9.

12.

The highly pathogenic H7N3 avian influenza strain from July 2012 in Mexico acquired an extended cleavage site through recombination with host 28S rRNA.

Maurer-Stroh S, Lee RT, Gunalan V, Eisenhaber F.

Virol J. 2013 May 1;10:139. doi: 10.1186/1743-422X-10-139.

13.

Investigation of causes of oseltamivir chemoprophylaxis failures during influenza A (H1N1-2009) outbreaks.

Lee VJ, Yap J, Maurer-Stroh S, Lee RT, Eisenhaber F, Tay JK, Ting PJ, Loh JP, Wong CW, Tan BH, Koay ES, Kelly PM, Hibberd ML.

J Clin Virol. 2011 Feb;50(2):104-8. doi: 10.1016/j.jcv.2010.10.004. Epub 2010 Nov 19.

PMID:
21094080
14.

All that glitters is not gold--founder effects complicate associations of flu mutations to disease severity.

Lee RT, Santos CL, de Paiva TM, Cui L, Sirota FL, Eisenhaber F, Maurer-Stroh S.

Virol J. 2010 Nov 1;7:297. doi: 10.1186/1743-422X-7-297.

Supplemental Content

Loading ...
Support Center